Road-MaptoCommercializingMedicalCannabisInnovation:fromLabtoPatient

לחולה במעבדה מהמחקר: רפואי בקנאביס חדשנות למסחור מדריך

TheconferencewillbeheldatWeWork,16HelkikeiHaorSt.,GevYamTechPark

Be’er-Sheva;Wednesday,January11,2017;17:30to20:00

forWazeTM:typeWeWorkBeer-Sheva;bytrain:BeerShevaNorthStation.

, מתחם WeWrok -, ב20:00עד 17:30, בשעות 2017בינואר 11-, ההכנס יערך ביום רביעי

.שבע -באר 3 קומה, 2 מספר בניין, 16 האור חלקיקי, רחובים-גב

(אוניברסיטה בן שבע. הגעה ברכבת: תחנת באר שבע צפון-באר WeWrokהגעה ברכב: להקליד בוייז

.גוריון)

Road-MaptoCommercializingMedicalCannabisInnovation:fromLabtoPatient

לחולה במעבדה מהמחקר: רפואי בקנאביס חדשנות למסחור מדריך

, מחקרים רוחני-בקנייןהיבטים המשלב בתחום הקנאביס הרפואי ראשוני מסוגו לכנס להזמינך גאים אנו -באר WeWorkבמתחם יערך הכנס. הרפואי הקנביס בעולם ולמשקיע ליזםמסחור קליניים, רגולציה ו

בקנאביס חדשנות למסחור מדריך המציג ייחודי מפגשזהו . צ"אחה 2017 בינואר 11', ד ביום שבע, המומחים טובי י"ע המוצגות) presentationssnapshot( קצרות הרצאות של שורה הכולל ,רפואי.זה ייעודי בתחום ואכיפה שימוש רישיונות מיסחורו מסחר סימני, הפטנטיםהרפואה, הרגולציה, בתחום

On11th January 2017, atWeWorkBe’er-Sheva,wewill be holding a first of its kindmeetingtopresentaroad-mapformedicalcannabisventurestofollowinordertobesuccessful.Thismeetingwillprovidean integratedoverviewof intellectualproperty,clinical trial data, regulatory affairs andbusiness investmentopportunities, essentialforphysicians,researchers,andentrepreneursactiveinmedicalcannabis.Severalkeyexperts inmedical cannabiswill describe thedifferentdisciplines vital for growth inthisarea.

Road-MaptoCommercializingMedicalCannabisInnovation:fromLabtoPatient

17:30-18:00 Registration&BEER18:00-18:15 History&FutureofCannabisClinicalResearch-KeynoteLecture

Prof.ZviBentwich,Head,CEMTAatBenGurionUniversity18:15-18:25 PatentTrendsinCanna-Tech

DrKerenHagai,PatentAttorney,HeadofLifeSciences18:25-18:40 LifeThreateningIdiopathicRecurrentAngioedemaRespondingto

CannabisDr.AmitFrenkel,GeneralIntensiveCareUnit,SorokaMedicalCenter

18:40-18:50 Marijuana,Wearables&theInternetofThingsDr.MotiZwilling(ComputerScience,BusinessAdministration),Adv.

18:50-19:00 OvercomingBarriersinProtectionforMarijuanaandCannabisTrademarksAviv-NicolasPollak,Adv.,TrademarkDept.

19:00-19:10 TheIsraelMedicalCannabisReform:NewRegulatoryStructureforResearch,Manufacturers,ClinicsandPatientsBennyShimony,Adv.,OdedSteiff,Sides&Co.Lawoffices

19:10-19:25 EvidenceBasedMedicineApproachtoMedicalCannabis-KeynotelectureProf.VictorNovack,Head,ClinicalResearchCenterandResearchAuthority,SorokaUniversityMedicalCenter

19:25-19:35 FinancialValuationofMedicalCannabisPatentsDrIlanRiess,ScientificAssociate

19:35-19:45 EpidemiologicalCharacteristicsofPatientsTreatedwithMedicalCannabisLihiBar-LevSchleider,ResearchManageratTikun-Olam

19:45-20:00 EconomicAspectsofMedicalCannabisRegulation:PharmaApproachvs.Whole-PlantSynergyDr.RevitalDuvdevani,CEOPharmaseedLtd

20:00-20:10 MedicalCannabisinChinaDrLimingWang,ScientificAssociate

20:10:-20:15 FarewellgreetingsDrJoeWyse,PatentAttorney,HeadofPatentDepartment

History&FutureofCannabisClinicalResearch

Prof.ZviBentwich BenGurionUniversity,Israel

ProfessorZviBentwich,isaphysicianclinicalimmunologistandworld-renownedexperton

AIDS research,withvast clinical, educationalandbiomedical researchexperience.Hewas

thefirstphysiciantodealwithAIDSinIsraelsince1982,andfounded

thefirstandlargestAIDScenterinthecountry.ProfessorBentwichis

Professor Emeritus ofMedicine of theHebrewUniversityHadassah

MedicalSchoolandcurrently,ProfessorofMicrobiologyImmunology

andGenetics,andheadoftheCenterforEmergingTropicalDiseases

& AIDS, at the Ben Gurion University. He is author of over 270 peer reviewed scientific

publications.Between2002to2009,Dr.BentwichwaschiefscientistofRosettaGenomics

Inc,(NASDAQROSG)andsince2012heisthescientificdirectoroftheEinGedi–DeadSea

AravaScienceCenterwhereheisdeeplyinvolvedinstudiesofmedicinalplantsandtheskin

microbiome. Since 2015 he is also chief scientist of Tikun Olam Ltd, the largest medical

cannabis company in Israel, where he leads several clinical trials of cannabis. Professor

Bentwichhasbeenboardmember(2002-2014)andchairman(2010-2012)ofPhysiciansfor

HumanRights, Israel.Amongotherawards,hehasreceivedin2010a lifetimeawardfrom

theIsraeliKnessetforhiscontributionstoIsraelMedicineandMedicalSciences.

EvidenceBasedMedicineApproachtoMedicalCannabis

Prof.VictorNovack HeadofSorokaClinicalResearchCenter

Prof.VictorNovackMD,PhDisafoundingdirectorofSorokaClinicalResearchCenter.Prior

to his current position, Prof. Novack served as a Medical Director at

HarvardClinicalResearch Institute.Hisepidemiology trainingallows for

the bridging a gap between the clinical questions and statistical

apparatus.Hehasdesignedandcontributedtothedesignofmorethan

50 feasibility andpivotal trials for FDAapproval. Prof.Novack is ProfessorofMedicineat

FacultyofHealthSciencesatBen-GurionUniversity,attendingintheDivisionofMedicineat

Soroka University Medical Center and Senior Scientist at Beth Israel Deaconess Medical

Center,HarvardMedical School.He is anAssociate and Statistical Editor of the European

JournalofInternalMedicine.Hehasmorethan150scientificpublicationsinpeerreviewed

journals.

Life Threatening Idiopathic Recurrent Angioedema

RespondingtoCannabis

Dr.AmitFrenkel

GeneralIntensiveCareUnit,SorokaMedicalCenter

Dr.AmitFrenkelistheheadofthecriticalcareoutreachunitatSorokaUniversityMedical

CenterandheadoftheDepartmentofEmergencyMedicineintheFacultyofHealth

SciencesofBen-GurionUniversityoftheNegev(BGU).

Dr.FrenkelisalecturerattheschoolofMedicine,FacultyofHealth

Sciences,BenGurionUniversityoftheNegev.Asamemberofthe

IsraeliGeneralIntensiveCareAssociation,heisthechairmanofthe

IntensiveCareExamsCommittee.DrFrenkelhasaccomplishedmany

awards,citations,honorsandCompetitiveFellowships.Inrecentyearsheaccomplishedthe

CEOPrizeforExcellentWorkatClalitHealthServicesandhasbeenawardedanexcellent

LecturerattheFacultyofHealthSciencesattheBenGurionUniversityoftheNegev.

Epidemiological Characteristics of Patients Treated with

MedicalCannabis

Lihi Bar-Lev Schleider Clinical Research Center, Soroka University

Medical Center and Faculty of Health Sciences, Ben-Gurion

UniversityoftheNegev,Be'er-Sheva,Israel.ResearchDepartment,

TikunOlamLtd,Israel.

EconomicAspectsofMedicalCannabisRegulation:Pharma

Approachvs.Whole-PlantSynergy

Dr.RevitalDuvdevani PharmaseedLtd DrDuvdevanihasaPh.DfromtheWeizmannInstitute,performedherpostdoctoratestudies

atRutgersUniversity in theUSandanMBA.DrDuvdevanihassignificant

experience in managing R&D in biotechnology start-ups in addition to

academic activity as a lecturer at the Department of Biotechnology Ben-

GurionUniversity.SheservedasPharmaseed’sVPR&Dfrom2010to2011.

From 2011 to 2016, she was director at the Weizmann Institute of Science, Davidson

Institute.AsofJune2016,sheisactingasPharmaseed’sCEO.

TheIsraelMedicalCannabisReform:NewRegulatory

StructureforResearch,Manufacturers,ClinicsandPatients

BennyShimony,Adv.OdedSteiff,Sides&Co.Lawoffices

Adv.BennyShimony leadstheBe’erShevabranchofOdedSteiff,Sides&Co.Lawoffices.

Adv. Shimony is responsible for obtaining regulatory permits and licenses for cannabis

producers,growers,manufacturersandimporters.Adv.IdanSidesisthepartnerresponsible

forthefirm’s IPdepartmentspecializing inenforcementof IPrightsbeforeall judicialand

governmental authorities (Copyright, Patent, Trade Marks, PBR, Trade Secrets).The firm

representsleadingmultinationalcorporationsinenforcementoftheirIPrights.

echTCannaMedicalPatentTrendsin

Dr.KerenHagaiDr.EyalBressler&Co.Ltd.KerenheadstheLifeScienceDept.,andhasexpertiseinavarietyofIPaspectsinBiotechand

Agriculture. Dr Hagai has particular experience in the areas of seed and

plant technology, improvedseed traits, classicalbreeding,plantgenetics,

newplantvarietiesandmolecularbiology.Shehasvastlypracticedpatent

searchesandanalysis,patentstrategy,patentdrafting,patentprosecution,

andFTOandpatentabilityopinions.KerenholdsPh.D. (Biochemistry),M.Sc. (PlantSciences)

andB.Sc.(Biology),allfromtheTelAvivUniversity.

technologiesandIPFinancialValuationofMedicalCannabis

thereof

Dr.IlanRiess Dr.EyalBressler&Co.Ltd.

Ilanheads thePBRDept. and is apatentexpert andaCRO,which

hasa vastexperience in researchanddevelopment, specializing in

different scientific fields.He has manager experience,including

administering budgets,problem solving, and ensuring

organization.He worked with extremely complex techniques that

requirehighlevelsofpreparation,rapidsituationassessment,flexibilityandadjustmentof

strategies.Hismulticulturalbackgroundprovideshimwithsingularperspectiveonthetasks

at hand.Ilanholds Ph.D. inMolecularMedicine, Biochemistry andCellular Biotechnology;

M.Sc. inMolecularBiotechnologyandB.Sc. inMolecularBiotechnology,all titlesare form

theUniversityofTurin(Italy).

OvercomingbarriersinprotectionforMarijuana&Cannabis

Trademarks

Aviv-NicolasPollak,Adv. Dr.EyalBressler&Co.Ltd.

AvivheadstheBrandProtection&EnforcementDepartmentandadvises

on trademarks and trademark related aspects, general intellectual

property rights protection, enforcement, computer and internet law,

various agreements and UDRP proceedings (domain names). Aviv holds

LL.B&LL.M(OAC/ColumbiaUniversityintheCityofNewYork).

Marijuana,Wearables&theInternetofThings

Dr.MotiZwilling(ComputerScience,BusinessAdministration),Adv.Dr.EyalBressler&Co.Ltd.

Dr.Moti Zwilling is affiliated to the senior academic stuff at the Department of Business

Administration and the Cyber Technology Research Center in Ariel

University. Dr. Zwilling is recognized in Intelligent Information Systems

andCyberSecurityandhasheldseveralleadingandconsultingpositions

in the industry in firms such as Gilat Satellite Networks, Check-Point,

Teva,AppliedMaterialsand theMinistryofDefensedirectly related to

thisfield.Hismainareasofexpertiseare:cybersecuritydataminingandmachinelearning,

pattern recognitionandbigdataanalysis especially inbusinessorientedDecisionSupport

Systems. Dr. Zwilling holds a B.Sc.,M.Sc. in Computer Science and Biology from Bar-Ilan

University,Ph.D.,inComputerScienceandBiologyfromTheHebrewUniversityofJerusalem

andM.B.A.,Ph.D., inMarketing fromBar-IlanUniversity.HealsohasB.A.andM.A inLaw

and is a certified lawyer of the Israeli bar association dealing with intellectual property

cases. Dr. Zwilling had worked as post-doc fellow researcher at the Deutsche Telekom’s

laboratoriesinthedomainofcybersecurity.

MedicalCannabisinChina

Dr.LiminWangDr.EyalBressler&Co.Ltd.

DrWanghasbroadhands-onresearchexperienceinmultiplefields,ranging

from chemistry to nuclear medicine. In her graduate research, she

developed a number of novel radiopharmaceuticals for early diagnosis of

cancer.HermulticulturalbackgroundenableshertohandleinternationalIP

cases in Asia and North America with unique capability. Limin holds PhD

(Biology)formtheUniversityofPennsylvania(USA)andB.Sc.fromPekingUniversity(China).

MonetizingMedicalCannabiswiththeIPToolbox

DrJoeIWyse&DrEyalBresslerDr.EyalBressler&Co.Ltd.

Joe is responsible for managing patent strategy and analysis and has achieved notable

successinachievingcrucialdefensiveandoffensivepatentprosecutions

andstrategies,whichhavebeenoftentranslatedtohighbalancesheet

valuesforourclients.Joedirectspatentvaluation,BDandCIanalysis

projects forvalidating that the technologyourclientshadselected is

the best-suited for their needs.Joe holds Ph.D. (Genetics) from the

UniversityofLondon.

Priortoformingthefirmandafterspending15yearsattheHebrewUniversityofJerusalem,

Eyal served as the CEO of a successful venture capital fund investing in

knowledge-intensive start-ups.Eyal's expertise in IP due diligence is

renownedandmateriallyimpactstheclient'sbusinessdecisions.Being

the author of various academic publications, Eyal is known as a

professional who is knowledgeable, skilled and up-to-date. Eyal holds

Ph.D. inBiotechnology from theHebrewuniversityof Jerusalem.He is patent attorney&

attorneyatlaw.